Quarterly report pursuant to Section 13 or 15(d)

EARNINGS (LOSS) PER SHARE (Tables)

v3.22.2.2
EARNINGS (LOSS) PER SHARE (Tables)
 9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
Three Months Ended September 30, Nine Months Ended September 30,
2022 2021 2022 2021
Numerator:
Net (loss) income and comprehensive (loss) income attributable to Jushi shareholders $ (54,696) $ 39,744  $ (62,387) $ 11,695 
Less undistributed net income (loss) for participating securities 455  (422) 532  (120)
Net (loss) income and comprehensive (loss) income - basic (54,241) 39,322  (61,855) 11,575 
Dilutive effect of net income from derivative warrants liability (6,396) (55,021) (63,277) (66,125)
Net loss and comprehensive loss attributable to Jushi shareholders - diluted $ (60,637) $ (15,699) $ (125,132) $ (54,550)
Denominator:
Weighted-average shares of common stock - basic 192,880,468  168,801,193  189,119,282  163,345,527 
Dilutive effect of derivative warrants 10,289,463  30,479,959  16,576,308  32,596,551 
Weighted-average shares of common stock - diluted 203,169,931  199,281,152  205,695,590  195,942,078 
Net (loss) income per common share attributable to Jushi:
Basic $ (0.28) $ 0.23  $ (0.33) $ 0.07 
Diluted $ (0.30) $ (0.08) $ (0.61) $ (0.28)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table summarizes equity instruments that may, in the future, have a dilutive effect on earnings (loss) per share, but were excluded from consideration in the computation of diluted net loss per share for the three and nine months ended September 30, 2022 and 2021, because the impact of including them would have been anti-dilutive:
September 30,
2022 2021
Stock options 28,428,120  10,921,452 
Warrants 28,840,202  28,995,403 
Unvested restricted stock awards 1,237,069  3,666,511 
Convertible promissory notes 910,000  910,000 
59,415,391  44,493,366